Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Viking Therapeutics a Buy?

TheMotleyFool

0 0

Nearly a year ago, Viking Therapeutics (NASDAQ: VKTX) became the darling of biotech investors. Shares skyrocketed in September 2018, after Viking announced positive results from a phase 2 clinical study of experimental drug VK2809.

Since then, though, it's been mainly downhill for Viking. Once-giddy investors realized that there's still a long way to go before VK2809 could reach the market. But is Viking Therapeutics a smart stock to buy now for investors with a long-term perspective?

Image source: Getty Images.

Source Fool.com

Like: 0

VKTX

Share